ChronoScale Holdings Corp: director resigns; $709,500 payment

What happened The filing says that, as previously announced, on Sep 30, 2026 ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary Ekso Bionics, Inc. In connection with the Transaction, Scott Davis, a member of the board and CEO of Ekso, resigned as a member of the board effective Oct 3, 2026. The filing reports that on Oct 2, 2026 the company granted Mr. Davis 51,626 restricted stock units that fully vested on the grant date and entered into a Release Agreement providing a lump sum cash payment of $709,500.

Key details

• RSUs: 51,626 restricted stock units granted to Scott Davis on Oct 2, 2026; they fully vested on the grant date.
• Cash payment: $709,500 lump sum, payable within 30 days of the Release Agreement, less applicable withholdings and deductions.
• Conditions: the Release Payment is subject to Mr. Davis’s compliance with the Release Agreement and his continuing restrictive covenants; in exchange he agreed to a general release of claims.
• Other agreements: the Release Agreement does not amend a Phantom Performance-Based RSU Agreement dated Nov 5, 2025 and was entered in lieu of any payment under a Change in Control and Severance Agreement disclosed Nov 7, 2025.

Why it may matter This filing is Item 5.02, which covers departure of directors or certain officers and related arrangements. The filing reports the director resignation and the related equity grant, lump sum payment, and release terms. The filing does not show why the insider traded or why the company acted.